Clinical Trial Update: Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety and feasibility clinical trial is evaluating autologous cord blood stem cell therapy for neonatal hypoxic-ischemic encephalopathy and is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hypoxic Ischemic Encephalopathy

Drugs mentioned

• Autologous Cord Blood Stem Cells

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Neonatal Hypoxic-ischaemic Encephalopathy | Phase 1, Phase 2 | Status: RECRUITING